Gründungssymposium des Centrums für Infektionsmedizin (CIM): Das CIM der #Uniklinik#Köln bündelt Sachverstand in der Infektionsmedizin. Gearbeitet wird an Best-Practice-Modellen für Patientenversorgung, translationale Forschung & Aus- und Weiterbildung. https://t.co/pP43t67q5d
Wie verändert sich die Antikörperantwort gegen #SARSCoV2 mit der Zeit und wie bereitet sich das Immunsystem mit klugen Strategien auf neue Varianten vor? Die AG von Prof. Klein @FKlein_Lab hat dazu Studien in @ImmunityCP und @SciImmunology veröffentlicht. https://t.co/4KJnc9hNTJ
Previously acquired bystander mutations can increase B cell diversity against variants.
Transferring a single bystander mutation restores the neutralizing activity of tixagevimab against BA.1/BA.2.
We are very happy to share our latest publication out in @ImmunityCP! Here we investigated how somatic hypermutation impacts SARS-CoV-2 neutralizing antibodies (https://t.co/ZGNwb8OkDQ).
Thanks a lot to our dear 🇮🇱 friends and collaborators @DiskinLab
Highlights include:
A fraction of mutated antibodies neutralizes Wu01 independently of the acquired mutations.
Germline VH1-58 mAbs neutralize Alpha, Beta, and Delta but require mutations for BA.1/BA.2.
Patient von #Leukämie und #HIV geheilt: Für die Heilung des „Düsseldorfer Patienten“ wurde ein interdisziplinäres Forschungsteam mit Beteiligung von Forschenden der #Uniklinik#Köln heute mit dem Preis der Deutschen #Hochschulmedizin 2023 ausgezeichnet. https://t.co/5Uu6DMDMX2
Congratulations Timm, Sabrina, and Svea to shed light on how #SARS-CoV-2 vaccination and breakthrough infections shape our antibody response. Now @SciImmunology. Thanks to all study participants and co-authors!
https://t.co/kOPrF4AFM3
🎉🏆Sieben Forschende der #UniKöln sind unter den meistzitierten Wissenschaftler*innen weltweit 🌍. Herzlichen Glückwunsch an unsere zwei Biolog*innen und fünf Mediziner, die zu den einflussreichtsen 1% ihres Faches gehören. 🧪🩺
#HighlyCited2023
Mehr 👇 https://t.co/G8V3SgOiUb
Excited to share our latest publication @ImmunityCP: "Analysis of the Human B Cell Response to HCMV in Top Neutralizers from a cohort of 9,000 Individuals"!
Congrats to @zehner_matthias, @Ashurov_Art and Mira and thanks to all collaboration partners!
https://t.co/VaVYPbdFYa
Just out: Our study on the dynamics of HIV-1 neutralization in over 2.300 individuals @NatureMedicine. Congratulations to Philipp (@SchommersP) and thanks to all our collaboration partners from around the world.
https://t.co/Rfo6iQACn6
Congratulations Christoph, Cosimo and Seda! Thank you very much Aleksandra Walczak, Thierry Mora, Andreas Beyer and all other co-authors for this great collaboration!
Happy to share the publication of our joined project between @FKlein_Lab and the Walczak/Mora Lab, where @wolphysics, Seda and myself investigated the probabilities of developing HIV-1 neutralizing antibody sequence features: https://t.co/YwjUzvrBjm
Happy to share the publication of our joined project between @FKlein_Lab and the Walczak/Mora Lab, where @wolphysics, Seda and myself investigated the probabilities of developing HIV-1 neutralizing antibody sequence features: https://t.co/YwjUzvrBjm
Check out how we applied our @FKlein_Lab antibody isolation workflows to target drug resistent bacteria in this fantastic cooperation with @SimonisLab, @JanRybniker and @DZIF_ colleagues…
We are happy to announce that our lab is the first on campus @UKKoeln to be awarded the highest level of certification (Green) by @My_Green_Lab!
https://t.co/2kBBi9yrYu
Excited about #AntibodyBasedTherapies workshop of the @DZIF_ bridging topic hosted @UKKoeln. Amazing talks by representatives from academic research, clinic & industry all coming together to advance the development, production & clinical testing of monoclonal antibodies.